Annual CFF
-$527.00 K
-$538.00 K-4890.91%
30 April 2024
Summary:
Champions Oncology annual cash flow from financing activities is currently -$527.00 thousand, with the most recent change of -$538.00 thousand (-4890.91%) on 30 April 2024. During the last 3 years, it has fallen by -$1.72 million (-144.10%). CSBR annual CFF is now -103.99% below its all-time high of $13.21 million, reached on 30 April 2015.CSBR Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$37.00 K
+$108.00 K+74.48%
31 July 2024
Summary:
Champions Oncology quarterly cash flow from financing activities is currently -$37.00 thousand, with the most recent change of +$108.00 thousand (+74.48%) on 31 July 2024. Over the past year, it has dropped by -$245.00 thousand (-117.79%). CSBR quarterly CFF is now -100.33% below its all-time high of $11.21 million, reached on 30 April 2015.CSBR Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$26.00 K
+$553.00 K+104.93%
31 July 2024
Summary:
Champions Oncology TTM cash flow from financing activities is currently $26.00 thousand, with the most recent change of +$553.00 thousand (+104.93%) on 31 July 2024. Over the past year, it has increased by +$483.00 thousand (+105.69%). CSBR TTM CFF is now -99.80% below its all-time high of $13.21 million, reached on 30 April 2015.CSBR TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSBR Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4890.9% | -117.8% | +105.7% |
| 3 y3 years | -144.1% | -130.6% | -81.3% |
| 5 y5 years | -143.8% | -640.0% | -83.2% |
CSBR Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -144.1% | at low | -117.8% | +93.7% | -90.1% | +104.5% |
| 5 y | 5 years | -111.9% | at low | -100.9% | +93.7% | -99.5% | +104.5% |
| alltime | all time | -104.0% | at low | -100.3% | +93.7% | -99.8% | +104.5% |
Champions Oncology Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| July 2024 | - | -$37.00 K(-74.5%) | $26.00 K(-104.9%) |
| Apr 2024 | -$527.00 K(-4890.9%) | -$145.00 K(<-9900.0%) | -$527.00 K(+15.3%) |
| Jan 2024 | - | $0.00(-100.0%) | -$457.00 K(0.0%) |
| Oct 2023 | - | $208.00 K(-135.3%) | -$457.00 K(-21.1%) |
| July 2023 | - | -$590.00 K(+686.7%) | -$579.00 K(-5363.6%) |
| Apr 2023 | $11.00 K(-94.7%) | -$75.00 K(<-9900.0%) | $11.00 K(-89.2%) |
| Jan 2023 | - | $0.00(-100.0%) | $102.00 K(-40.0%) |
| Oct 2022 | - | $86.00 K(>+9900.0%) | $170.00 K(-17.1%) |
| July 2022 | - | $0.00(-100.0%) | $205.00 K(-1.0%) |
| Apr 2022 | $207.00 K(-82.7%) | $16.00 K(-76.5%) | $207.00 K(-21.3%) |
| Jan 2022 | - | $68.00 K(-43.8%) | $263.00 K(+89.2%) |
| Oct 2021 | - | $121.00 K(+5950.0%) | $139.00 K(-88.9%) |
| July 2021 | - | $2000.00(-97.2%) | $1.25 M(+5.0%) |
| Apr 2021 | $1.20 M(-73.0%) | $72.00 K(-228.6%) | $1.20 M(-76.9%) |
| Jan 2021 | - | -$56.00 K(-104.5%) | $5.17 M(-7.9%) |
| Oct 2020 | - | $1.24 M(-2232.8%) | $5.61 M(+28.4%) |
| July 2020 | - | -$58.00 K(-101.4%) | $4.37 M(-1.2%) |
| Apr 2020 | $4.42 M(+267.4%) | $4.04 M(+936.4%) | $4.42 M(+2178.4%) |
| Jan 2020 | - | $390.00 K(-7900.0%) | $194.00 K(+25.2%) |
| Oct 2019 | - | -$5000.00(-28.6%) | $155.00 K(-86.6%) |
| July 2019 | - | -$7000.00(-96.2%) | $1.16 M(-3.5%) |
| Apr 2019 | $1.20 M(+9153.8%) | -$184.00 K(-152.4%) | $1.20 M(-12.9%) |
| Jan 2019 | - | $351.00 K(-64.9%) | $1.38 M(+30.0%) |
| Oct 2018 | - | $1.00 M(+2760.0%) | $1.06 M(+1830.9%) |
| July 2018 | - | $35.00 K(-683.3%) | $55.00 K(+323.1%) |
| Apr 2018 | $13.00 K(-99.7%) | -$6000.00(-118.8%) | $13.00 K(0.0%) |
| Jan 2018 | - | $32.00 K(-633.3%) | $13.00 K(-152.0%) |
| Oct 2017 | - | -$6000.00(-14.3%) | -$25.00 K(0.0%) |
| July 2017 | - | -$7000.00(+16.7%) | -$25.00 K(-100.6%) |
| Apr 2017 | $4.32 M(<-9900.0%) | -$6000.00(0.0%) | $4.32 M(+0.0%) |
| Jan 2017 | - | -$6000.00(0.0%) | $4.32 M(0.0%) |
| Oct 2016 | - | -$6000.00(-100.1%) | $4.32 M(-0.0%) |
| July 2016 | - | $4.33 M(<-9900.0%) | $4.32 M(<-9900.0%) |
| Apr 2016 | -$42.00 K(-100.3%) | -$7000.00(+16.7%) | -$42.00 K(-100.4%) |
| Jan 2016 | - | -$6000.00(+50.0%) | $11.18 M(-15.2%) |
| Oct 2015 | - | -$4000.00(-84.0%) | $13.18 M(-0.0%) |
| July 2015 | - | -$25.00 K(-100.2%) | $13.19 M(-0.2%) |
| Apr 2015 | $13.21 M(>+9900.0%) | $11.21 M(+462.1%) | $13.21 M(+554.6%) |
| Jan 2015 | - | $2.00 M(>+9900.0%) | $2.02 M(>+9900.0%) |
| Oct 2014 | - | $2000.00(>+9900.0%) | $14.00 K(-33.3%) |
| July 2014 | - | $0.00(-100.0%) | $21.00 K(0.0%) |
| Apr 2014 | $21.00 K(-99.8%) | $21.00 K(-333.3%) | $21.00 K(-138.9%) |
| Jan 2014 | - | -$9000.00(-200.0%) | -$54.00 K(-100.6%) |
| Oct 2013 | - | $9000.00(>+9900.0%) | $9.15 M(+0.1%) |
| July 2013 | - | $0.00(-100.0%) | $9.14 M(0.0%) |
| Apr 2013 | $9.14 M(+9323.7%) | -$54.00 K(-100.6%) | $9.14 M(-0.6%) |
| Jan 2013 | - | $9.20 M(>+9900.0%) | $9.19 M(<-9900.0%) |
| Oct 2012 | - | $0.00(0.0%) | -$1000.00(-101.1%) |
| July 2012 | - | $0.00(-100.0%) | $93.00 K(-4.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2012 | $97.00 K(-98.8%) | -$1000.00(<-9900.0%) | $97.00 K(-98.8%) |
| Jan 2012 | - | $0.00(-100.0%) | $8.25 M(-0.0%) |
| Oct 2011 | - | $94.00 K(+2250.0%) | $8.25 M(+1.7%) |
| July 2011 | - | $4000.00(-100.0%) | $8.12 M(+0.4%) |
| Apr 2011 | $8.08 M(+302.7%) | $8.15 M(>+9900.0%) | $8.08 M(>+9900.0%) |
| Jan 2011 | - | $2000.00(-104.8%) | $46.00 K(-97.8%) |
| Oct 2010 | - | -$42.00 K(+35.5%) | $2.12 M(-0.5%) |
| July 2010 | - | -$31.00 K(-126.5%) | $2.13 M(+6.1%) |
| Apr 2010 | $2.01 M(+3421.1%) | $117.00 K(-94.4%) | $2.01 M(+3.5%) |
| Jan 2010 | - | $2.08 M(-6584.4%) | $1.94 M(-1442.6%) |
| Oct 2009 | - | -$32.00 K(-79.1%) | -$144.50 K(+40.3%) |
| July 2009 | - | -$153.00 K(-406.0%) | -$103.00 K(-280.7%) |
| Apr 2009 | $57.00 K(-97.7%) | $50.00 K(-626.3%) | $57.00 K(-97.7%) |
| Jan 2009 | - | -$9500.00(-200.0%) | $2.51 M(-1.5%) |
| Oct 2008 | - | $9500.00(+35.7%) | $2.55 M(+0.4%) |
| July 2008 | - | $7000.00(-99.7%) | $2.54 M(+2.0%) |
| Apr 2008 | $2.49 M(+2946.5%) | $2.50 M(+8686.7%) | $2.49 M(<-9900.0%) |
| Jan 2008 | - | $28.50 K(>+9900.0%) | -$15.20 K(-1620.0%) |
| Oct 2007 | - | $0.00(-100.0%) | $1000.00(-97.4%) |
| July 2007 | - | -$43.70 K(<-9900.0%) | $38.00 K(-53.5%) |
| Apr 2007 | $81.70 K(>+9900.0%) | $0.00(-100.0%) | $81.70 K(0.0%) |
| Jan 2007 | - | $44.70 K(+20.8%) | $81.70 K(+120.8%) |
| Oct 2006 | - | $37.00 K(>+9900.0%) | $37.00 K(>+9900.0%) |
| July 2006 | - | $0.00(0.0%) | $0.00(0.0%) |
| Apr 2006 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Jan 2006 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Oct 2005 | - | $0.00(0.0%) | -$9100.00(-927.3%) |
| July 2005 | - | $0.00(0.0%) | $1100.00(>+9900.0%) |
| Apr 2005 | $0.00(-100.0%) | $0.00(-100.0%) | $0.00(-100.0%) |
| Jan 2005 | - | -$9100.00(-189.2%) | -$4400.00(-193.6%) |
| Oct 2004 | - | $10.20 K(-1027.3%) | $4700.00(-185.5%) |
| July 2004 | - | -$1100.00(-75.0%) | -$5500.00(+25.0%) |
| Apr 2004 | -$4400.00(-241.9%) | -$4400.00(<-9900.0%) | -$4400.00(-188.0%) |
| Jan 2004 | - | $0.00(0.0%) | $5000.00(0.0%) |
| Oct 2003 | - | $0.00(0.0%) | $5000.00(0.0%) |
| July 2003 | - | $0.00(-100.0%) | $5000.00(+61.3%) |
| Apr 2003 | $3100.00(-93.1%) | $5000.00(>+9900.0%) | $3100.00(-93.8%) |
| Jan 2003 | - | $0.00(0.0%) | $50.30 K(+5.7%) |
| Oct 2002 | - | $0.00(-100.0%) | $47.60 K(+5.5%) |
| July 2002 | - | -$1900.00(-103.6%) | $45.10 K(+1.1%) |
| Apr 2002 | $44.70 K(-632.1%) | $52.20 K(-2033.3%) | $44.60 K(-550.5%) |
| Jan 2002 | - | -$2700.00(+8.0%) | -$9900.00(+5.3%) |
| Oct 2001 | - | -$2500.00(+4.2%) | -$9400.00(+5.6%) |
| July 2001 | - | -$2400.00(+4.3%) | -$8900.00(+6.0%) |
| Apr 2001 | -$8400.00(+42.4%) | -$2300.00(+4.5%) | -$8400.00(+37.7%) |
| Jan 2001 | - | -$2200.00(+10.0%) | -$6100.00(+56.4%) |
| Oct 2000 | - | -$2000.00(+5.3%) | -$3900.00(+105.3%) |
| July 2000 | - | -$1900.00 | -$1900.00 |
| Apr 2000 | -$5900.00 | - | - |
FAQ
- What is Champions Oncology annual cash flow from financing activities?
- What is the all time high annual CFF for Champions Oncology?
- What is Champions Oncology annual CFF year-on-year change?
- What is Champions Oncology quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Champions Oncology?
- What is Champions Oncology quarterly CFF year-on-year change?
- What is Champions Oncology TTM cash flow from financing activities?
- What is the all time high TTM CFF for Champions Oncology?
- What is Champions Oncology TTM CFF year-on-year change?
What is Champions Oncology annual cash flow from financing activities?
The current annual CFF of CSBR is -$527.00 K
What is the all time high annual CFF for Champions Oncology?
Champions Oncology all-time high annual cash flow from financing activities is $13.21 M
What is Champions Oncology annual CFF year-on-year change?
Over the past year, CSBR annual cash flow from financing activities has changed by -$538.00 K (-4890.91%)
What is Champions Oncology quarterly cash flow from financing activities?
The current quarterly CFF of CSBR is -$37.00 K
What is the all time high quarterly CFF for Champions Oncology?
Champions Oncology all-time high quarterly cash flow from financing activities is $11.21 M
What is Champions Oncology quarterly CFF year-on-year change?
Over the past year, CSBR quarterly cash flow from financing activities has changed by -$245.00 K (-117.79%)
What is Champions Oncology TTM cash flow from financing activities?
The current TTM CFF of CSBR is $26.00 K
What is the all time high TTM CFF for Champions Oncology?
Champions Oncology all-time high TTM cash flow from financing activities is $13.21 M
What is Champions Oncology TTM CFF year-on-year change?
Over the past year, CSBR TTM cash flow from financing activities has changed by +$483.00 K (+105.69%)